Larvol Delta - Continued-Access-to-Deucravacitinib-for-Adult-SLESjD-and-Pediatric-PsOPsA-Study-Completers

Sotyktu (deucravacitinib) - BMS

http://clinicaltrials.gov/ct2/show/NCT07791199

Sep 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next